Pharmacoeconomics

The health service budget is limited and expenditure on medicinal products in Slovakia is constantly rising. This pushes pharmacoeconomics to the forefront of drug policy and pharmaceutical companies must demonstrate the cost-effectiveness and budget impact of new drugs being introduced to the market.

Our Pharmacoeconomic services include:

• elaboration of local pharmacoeconomic analyses in line with legislative requirements and methodical guidelines
• feasibility studies that evaluate whether a drug satisfies the legislative criteria for inclusion to the reimbursement system and calculation of the price at which the drug is cost-effective under Slovak conditions
• adaptation of global pharmacoeconomic models accounting for local input data
• preparation of local “value dossier“, including a description of the current situation in treatment, unmet treatment needs, the clinical benefit of new intervention, description of pharmacoeconomic analysis and budget impact analysis